Johnson & Johnson reported strong operational performance in the quarter, demonstrating the power and adaptability of Johnson & Johnson as well as its dedication to enhancing global health outcomes. The company delivered an all-around beat and the management remains committed to successfully separating its Consumer Health company, Kenvue, which will enable the companies to be more agile, persistent, and competitive. They also anticipate a number of pipeline advances in 2023 that will boost confi ....
